跳至主要内容
临床试验/IRCT2015120816837N2
IRCT2015120816837N2已完成2 期

Effects of oral calcitriol versus placebo on hematologic and immunologic reconstitution after autologous hematopoietic stem cell transplantation: a double-blind, randomized clinical trial

Research Center of the Hematology and Oncology and Stem Cell Transplantation, Shariati Hospital, Teh0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 65 years(—)
性别
All

入选标准

  • age between 16 and 65 years; cases of Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, or multiple myelomas; candidates for autologous peripheral blood hematopoietic stem cell transplantation. Exclusion criteria: baseline serum calcium >10.5mg/dL; baseline serum phosphorous >4.5mg/dL;history of renal stones in the past 5 years; baseline serum creatinine >1.3mg/dL; alkaline phosphatase x4 the upper limit of normal or higher; alanine transaminase >60U/L; total bilirubin >2mg/dL; sensitivity to calcitriol; disability for oral intake.

排除标准

  • 未提供

研究者

发起方
Research Center of the Hematology and Oncology and Stem Cell Transplantation, Shariati Hospital, Teh

相似试验